Why Need to Watch: Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Louisiana-Pacific Corp. (NYSE:LPX), Alcatel Lucent (NYSE:ALU), Cascade Bancorp (NASDAQ:CACB)

On 30 July, Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) announced financial results for the second quarter of 2015. Navidea reported total revenue for the second quarter of 2015 of $2.9 million, including Lymphoseek® (technetium Tc 99m tilmanocept) injection sales revenue of $2.0 million. The net loss from operations was $3.8 million and the net loss attributable to common stockholders was $9.7 million. Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) belongs to Healthcare sector. On last trading day company shares ended up $1.70. Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) distance from 50-day simple moving average (SMA50) is 5.71%.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that the Company will host its second quarter 2015 financial results conference call and live webcast on Monday, August 10 at 8:30 AM ET. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares moved down -5.29% in last trading session and ended the day at $6.80. INO return on assets is -27.30%. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) quarterly performance is -15.84%.

On 4 August, Louisiana-Pacific Corp. (NYSE:LPX) reported Q2 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $493 million versus the consensus estimate of $509.13 million. On 06 August, Louisiana-Pacific Corp. (NYSE:LPX) shares increased 1.35% and was closed at $15.81. LPX EPS growth in last 5 year was 13.10%. Louisiana-Pacific Corp. (NYSE:LPX) year to date (YTD) performance is -4.53%.

On 31 Jul, Alcatel Lucent SA (ADR) (NYSE:ALU) reported adjusted loss of 2 cents per American Depositary Share (“ADS”) for second-quarter 2015, which compared unfavorably with the Zacks Consensus Estimate of earnings of 2 cents. However, the loss narrowed from the prior-year quarter loss of 15 cents. Alcatel Lucent SA (ADR) (NYSE:ALU) shares decreased -0.54% in last trading session and ended the day at $3.65. ALU Gross Margin is 34.00% and its return on assets is -0.90%. Alcatel Lucent SA (ADR) (NYSE:ALU) quarterly performance is 0.27%.

On 28 July, Cascade Bancorp (NASDAQ:CACB) announced its financial results for the three and six months ended June 30, 2015. Net income for the second quarter of 2015 was $4.8 million, or $0.07 per share, compared to $5.1 million, or $0.07 per share, for the first quarter of 2015 (“linked quarter”). First quarter 2015 benefited from a $2.0 million credit to the loan loss provision (pretax), or $0.02 per share. There was no loan loss provision in the current quarter. Cascade Bancorp (NASDAQ:CACB) shares increased 1.11% in last trading session and ended the day at $5.45. CACB return on assets is 0.70%. Cascade Bancorp (NASDAQ:CACB) quarterly performance is 12.37%.

Leave a Reply

Your email address will not be published. Required fields are marked *